GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Laboratorio Reig Jofre RJF.MC · EUR

Health Care · BME · 🇪🇸 Spain

Compare

2.56

0.00%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2024

Revenue

€338.9m

FY2015FY2024

Net income

€10.4m

FY2015FY2024

Free cash flow

€10.6m

FY2015FY2024

Shareholders' equity

€214.0m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue€338.9m€316.1m€271.1m€236.2m€230.1m€200.2m€180.5m€168.0m€161.1m€156.9m
Gross profit€201.2m€184.2m€161.1m€148.4m€144.0m€131.9m€117.7m€107.6m€100.1m€97.8m
Research and development———€4.9m€3.8m€4.0m€4.1m€3.7m€3.3m€2.5m
Operating income€15.0m€12.2m€9.5m€9.3m€9.6m€6.6m€8.8m€9.0m€9.8m€11.8m
Net income€10.4m€9.4m€8.1m€5.1m€5.7m€4.9m€9.3m€8.8m€7.7m€8.7m
Diluted earnings per share0.130.120.100.060.070.070.130.130.110.13

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets€344.9m€330.5m€321.2m€325.0m€317.2m€313.6m€219.7m€203.3m€205.3m€187.1m
Cash and short-term investments€23.0m€6.5m€6.9m€6.0m€12.4m€11.1m€11.0m€15.0m€19.3m€11.8m
Total liabilities€130.9m€126.2m€126.6m€136.4m€132.6m€135.4m€69.9m€61.7m€72.0m€60.9m
Debt€58.5m€53.5m€61.2m€67.4m€57.0m€56.6m€26.2m€23.2m€30.5m€17.7m
Shareholders' equity€214.0m€204.4m€194.6m€188.6m€184.5m€178.2m€149.8m€141.6m€133.3m€126.2m
Shares outstanding81m80m80m79m79m73m69m67m68m67m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations€31.3m€19.1m€16.1m€14.5m€22.5m€11.7m€14.8m€20.7m−€1.5m€12.9m
Capital spending−€20.8m−€12.8m−€11.4m−€19.8m−€15.9m−€31.1m−€21.1m−€17.6m−€12.2m−€10.5m
Free cash flow€10.6m€6.3m€4.7m−€5.3m€6.6m−€19.5m−€6.3m€3.1m−€13.7m€2.4m
Dividends paid−€25,000−€41,000−€53,000−€55,000−€88,000−€359,000−€380,100−€50,100−€8,900−€26,100

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.8%11.1%26.1%
Operating income17.3%18.0%18.3%
Net income26.8%16.0%16.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin58.8%59.8%61.0%61.7%
Operating margin4.2%4.0%3.9%4.6%
Net margin3.0%2.8%2.7%3.5%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings19.519.221.750.661.337.517.117.827.626.3
Price to sales0.60.60.71.11.50.90.90.91.31.5

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 21 May 2026.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.0490.040.040.9950.0440.0380.0440.044
  • 20-to-1 reverse split · 22 Sept 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.